Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(34:2e)/PE(34:1p) | Lipid-depleted/compactin | 0.0 | BCD100624C002 | 119 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | Lipid-depleted/compactin | 0.5 | BCD100624C005 | 133 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | Lipid-depleted/compactin | 1.0 | BCD100624C009 | 37.2 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | Lipid-depleted/compactin | 2.0 | BCD100624C013 | - | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | Lipid-depleted/compactin | 4.0 | BCD100624C017 | 104 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | Lipid-depleted/compactin | 8.0 | BCD100624C021 | 165 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | Lipid-depleted/compactin | 12.0 | BCD100624C025 | 197 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | Lipid-depleted/compactin | 24.0 | BCD100624C029 | 43.7 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | C | 0.0 | BCD100624C001 | 92.5 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | C | 0.5 | BCD100624C003 | 103 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | C | 1.0 | BCD100624C007 | 27.4 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | C | 2.0 | BCD100624C011 | 72.3 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | C | 4.0 | BCD100624C015 | 45.2 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | C | 8.0 | BCD100624C019 | 84 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | C | 12.0 | BCD100624C023 | 111 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | C | 24.0 | BCD100624C027 | 74.1 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100624C006 | 124 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100624C010 | - | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100624C014 | 88.3 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100624C018 | 30.7 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100624C022 | 29.8 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100624C026 | 111 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100624C030 | 41.6 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol | 0.5 | BCD100624C004 | 136 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol | 1.0 | BCD100624C008 | 155 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol | 2.0 | BCD100624C012 | 106 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol | 4.0 | BCD100624C016 | - | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol | 8.0 | BCD100624C020 | 66.5 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol | 12.0 | BCD100624C024 | 17.2 | pmol/sample |
| - | PE(34:2e)/PE(34:1p) | 25OH-Chol | 24.0 | BCD100624C028 | 209 | pmol/sample |